UBS Group’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $19.1M | Buy |
|
|||||
|
2025
Q2 | $8.03M | Sell |
|
|||||
|
2025
Q1 | $4.92M | Buy |
|
|||||
|
2024
Q4 | $2.43M | Buy |
|
|||||
|
2024
Q3 | $742K | Buy |
|
|||||
|
2024
Q2 | $57.3K | Sell |
|
|||||
|
2024
Q1 | $598K | Buy |
|
|||||
|
2023
Q4 | $574K | Buy |
|
|||||
|
2023
Q3 | $84.4K | Sell |
|
|||||
|
2023
Q2 | $1.6M | Buy |
|
|||||
|
2023
Q1 | $1.37M | Buy |
|
|||||
|
2022
Q4 | $128K | Sell |
|
|||||
|
2022
Q3 | $112K | Buy |
|
|||||
|
2022
Q2 | $3K | Sell |
|
|||||
|
2022
Q1 | $53K | Buy |
|